X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ELDER PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ELDER PHARMA WYETH LTD/
ELDER PHARMA
 
P/E (TTM) x 27.7 -0.2 - View Chart
P/BV x 5.3 0.1 5,300.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   ELDER PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ELDER PHARMA
Jun-14
WYETH LTD/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs1,044380 274.8%   
Low Rs818188 435.1%   
Sales per share (Unadj.) Rs298.6491.2 60.8%  
Earnings per share (Unadj.) Rs57.2-3.2 -1,799.1%  
Cash flow per share (Unadj.) Rs58.414.4 405.4%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.5376.5 66.3%  
Shares outstanding (eoy) m22.7220.54 110.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.6 539.4%   
Avg P/E ratio x16.3-89.3 -18.2%  
P/CF ratio (eoy) x15.919.7 80.9%  
Price / Book Value ratio x3.70.8 494.9%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1575,833 362.7%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4002,179 18.4%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,78310,089 67.2%  
Other income Rs m353257 137.4%   
Total revenues Rs m7,13610,346 69.0%   
Gross profit Rs m1,617-792 -204.2%  
Depreciation Rs m27361 7.4%   
Interest Rs m62,756 0.2%   
Profit before tax Rs m1,938-3,653 -53.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-53,713 -0.1%   
Tax Rs m632125 505.2%   
Profit after tax Rs m1,301-65 -1,990.1%  
Gross profit margin %23.8-7.8 -303.8%  
Effective tax rate %32.6-3.4 -952.3%   
Net profit margin %19.2-0.6 -2,959.8%  
BALANCE SHEET DATA
Current assets Rs m6,9849,240 75.6%   
Current liabilities Rs m2,0569,998 20.6%   
Net working cap to sales %72.6-7.5 -967.3%  
Current ratio x3.40.9 367.6%  
Inventory Days Days9946 214.4%  
Debtors Days Days2460 39.9%  
Net fixed assets Rs m24410,124 2.4%   
Share capital Rs m227206 110.5%   
"Free" reserves Rs m5,4415,582 97.5%   
Net worth Rs m5,6687,734 73.3%   
Long term debt Rs m254,889 0.5%   
Total assets Rs m7,90122,882 34.5%  
Interest coverage x353.3-0.3 -108,618.8%   
Debt to equity ratio x00.6 0.7%  
Sales to assets ratio x0.90.4 194.7%   
Return on assets %16.511.8 140.6%  
Return on equity %22.9-0.8 -2,715.3%  
Return on capital %34.022.3 152.6%  
Exports to sales %0.23.0 7.2%   
Imports to sales %36.30.4 8,507.7%   
Exports (fob) Rs m15307 4.8%   
Imports (cif) Rs m2,46543 5,720.2%   
Fx inflow Rs m15307 5.0%   
Fx outflow Rs m2,677125 2,136.6%   
Net fx Rs m-2,662181 -1,468.3%   
CASH FLOW
From Operations Rs m92311,754 7.9%  
From Investments Rs m317-561 -56.5%  
From Financial Activity Rs m-481-6,762 7.1%  
Net Cashflow Rs m7594,432 17.1%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 7.5 150.7%  
FIIs % 7.2 16.8 42.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 36.1 84.2%  
Shareholders   21,978 16,479 133.4%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   ORCHID PHARMA LTD  CIPLA  TORRENT PHARMA  ALEMBIC LTD  DR. REDDYS LAB  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades 370 Points Up; Hero MotoCorp & Tata Motors Gain Over 5%(12:30 pm)

Stock markets in India are presently trading higher following the outcome of assembly polls announced on Tuesday.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - ORCHID PHARMA LTD COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS